Arca
Skip to content
Tools
Tools

AnyScan 3.0 NM Scanner Family

System, Tomography, Computed, Emission. 510(k) K253844, from Mediso Medical Imaging Systems, Ltd. (Budapest, HU). Product code KPS, class 2.

As of Nov 21, 2026, K253844 is an FDA 510(k) held by Mediso Medical Imaging Systems, Ltd., substantially equivalent on Dec 30, 2025 after 28 days, with no recalls tied to it in FDA's recall database.

  • Review time: 28 days
  • Recalls: 0

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF
  • Symbia 6.7K200474 · Siemens Medical Solutions USA, Inc. · Mar 20, 2020
  • Biograph HorizonK193178 · Siemens Medical Solution USA, Inc. · Feb 12, 2020

Other KPS clearances

The newest 510(k)s for the same product code; their median review was 89 days; see every KPS device

Record

Type
Traditional, third-party review
Received
Dec 2, 2025
Review panel
Radiology
Regulation
21 CFR 892.1200

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.